The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT
Status:
Recruiting
Trial end date:
2021-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to verify that simultaneous integrated boost IMRT (SIB-IMRT)
alone is non-inferior to SIB-IMRT combined with concurrent chemotherapy for low-risk locally
advanced nasopharyngeal carcinoma.